Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 401 - 420 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 21  22  23  24  25 »
Reset 

MSI Methylation Sciences, Inc. (MSI) provides an update on its corporate activities, including its recent arbitration award of $20 million USD against Quark Venture Inc (Quark)

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  MSI Methylation Sciences Inc

Translate Bio to Present Preclinical Data Supporting MRT5005 at the 32nd Annual North American Cystic Fibrosis Conference

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  TRANSLATE BIO

Biogen to Present Data from Alzheimer’s Disease Portfolio at the 2018 Clinical Trials on Alzheimer’s Disease (CTAD) Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Biogen Inc.

scPharmaceuticals Inc. Provides Regulatory Update on FUROSCIX®

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  scPharmaceuticals Inc.

Innovation Behind Precipio’s ICE-COLD PCR™ Platform Spotlighted in Media

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Precipio Diagnostics

Opiant Pharmaceuticals Announces Receipt of National Institutes of Health Grant by Walter Reed Army Institute of Research and SUNY Upstate Medical University for Development of a Heroin Vaccine

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Opiant Pharmaceuticals, Inc.

Delcath Announces Enrollment of First Patient in ALIGN Trial

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Delcath Systems Inc.

Zosano Pharma to Host Key Opinion Leader Meeting on New Treatments for Migraine and the Migraine Patients’ Perspective

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Zosano Pharma, Inc.

Spectral Announces Presentation at the European Society of Intensive Care Medicine Oct 22nd and Publication of Overall Results of the EUPHRATES trial in JAMA

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Spectral Medical Inc.

Matinas BioPharma Announces Issuance of Key U.S. Patent for Prescription-Only Next Generation Omega-3 MAT9001 Providing Protection Through 2033

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Matinas BioPharma Holdings Inc.

Allena Pharmaceuticals Highlights Ongoing Efforts to Address Rare and Severe Metabolic Disorders Affecting the Kidney with Presentations at Upcoming Medical Meetings

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Allena Pharmaceuticals, Inc.

Samumed to Present Preclinical Data on SM07883 at the 11th Clinical Trials on Alzheimer’s Disease (CTAD) Congress

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Samumed LLC

swyMed Joins AT&T's FirstNet Dealer Program

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018

Evolus to Release Third Quarter 2018 Financial Results on Monday, November 5, 2018

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  EVOLUS, INC.

Progressive Care Inc. Announces Beta Launch of New Proprietary Tele-PharmCo Software Platform for Real-Time Patient-to-Pharmacist Video Interactions

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018

Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Abeona Therapeutics, Inc.

Organovo Announces Release Date for Fiscal Second-Quarter 2019 Financial Results

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Organovo Holdings, Inc.

OpGen Announces Pricing of Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  OpGen, Inc.

Intellia Therapeutics Presents New Data in In Vivo and Ex Vivo Programs at the 26th Annual Congress of the European Society of Gene and Cell Therapy

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Intellia Therapeutics, Inc.

Ultragenyx Announces Approval of Mepsevii™ (vestronidase alfa) in Brazil for the Treatment of Mucopolysaccharidosis VII

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Ultragenyx Pharmaceutical, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 21  22  23  24  25 »
to the top ↑